Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity ...
Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...
XOMA Royalty’s CEO Owen Hughes and CIO Brad Sitko explain how royalty investing mitigates risks while expediting biotech drug development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback